Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance
- PMID: 16608980
- DOI: 10.1093/annonc/mdj920
Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance
Similar articles
-
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.Ann Oncol. 2006 Mar;17 Suppl 2:ii49-51. doi: 10.1093/annonc/mdj922. Ann Oncol. 2006. PMID: 16608982 Review. No abstract available.
-
Combination of biological therapies in non-small cell lung cancer.Ann Oncol. 2006 Mar;17 Suppl 2:ii52-54. doi: 10.1093/annonc/mdj923. Ann Oncol. 2006. PMID: 16608984 Review. No abstract available.
-
Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer.Ann Oncol. 2006 Mar;17 Suppl 2:ii46-48. doi: 10.1093/annonc/mdj921. Ann Oncol. 2006. PMID: 16608981 Review.
-
EGFR-TK1-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients with NSCLC: When Is it Worth The Risk?Pathol Oncol Res. 2019 Oct;25(4):1665-1666. doi: 10.1007/s12253-019-00599-z. Epub 2019 Jan 19. Pathol Oncol Res. 2019. PMID: 30661223 No abstract available.
-
Combined modality therapy for non-small cell lung cancer, past, present, and future.Lung Cancer. 2003 Dec;42 Suppl 2:S35-40. doi: 10.1016/j.lungcan.2003.08.009. Lung Cancer. 2003. PMID: 14644534 Review. No abstract available.
Cited by
-
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.Int J Oncol. 2009 Jul;35(1):57-68. doi: 10.3892/ijo_00000313. Int J Oncol. 2009. PMID: 19513552 Free PMC article.
-
EGFR-mutated lung cancer: a paradigm of molecular oncology.Oncotarget. 2010 Nov;1(7):497-514. doi: 10.18632/oncotarget.186. Oncotarget. 2010. PMID: 21165163 Free PMC article. Review.
-
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.Arch Virol. 2021 Mar;166(3):675-696. doi: 10.1007/s00705-021-04958-7. Epub 2021 Jan 18. Arch Virol. 2021. PMID: 33462671 Free PMC article. Review.
-
Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer.Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):293-302. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24982815 Free PMC article.
-
Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer.Curr Cancer Drug Targets. 2012 Feb;12(2):107-23. doi: 10.2174/156800912799095144. Curr Cancer Drug Targets. 2012. PMID: 22165970 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous